This site uses cookies to ensure the best viewing experience for our readers.
CTech's Tuesday Roundup of Israeli Tech News

CTech's Tuesday Roundup of Israeli Tech News

Electronics health company ProteanTecs emerges from stealth with a $35 million investment

CTech | 14:39, 02.04.19
Electronics health company ProteanTecs emerges from stealth with a $35 million investment. ProteanTecs develops technology for predicting failures in electronic systems. The company was founded by three co-founders of Israeli chipmaker Mellanox. Read more
Haifa. Photo: Elad Gershgoren Haifa. Photo: Elad Gershgoren Haifa. Photo: Elad Gershgoren

Intel Capital reorganizes Israeli team after investing $120 million in local startups in 2018. The Israeli team intends to collaborate with other corporate investment funds such as Samsung and Qualcomm. Read more

Mind the Tech NY | Silicon shtetl: these Haredi startups are headed to New York. The startups will take part in Calcalist’s third annual Mind the Tech Conference, taking place in New York next week. Read more

Liquidity Capital announces close of $30 million revenue-share financing fund. Liquidity, of Israeli investment house Meitav Dash, will use the funds to invest in companies with annual revenues of over $3 million. Read more  

Dutch Firm Wins Bid to Examine Building Artificial Airport Island Off Israeli Coast. In 2002, the Israeli government approved a plan to construct two man-made islands off the country’s shores, designating one for an international airport and one for housing. Read more

Cybersecurity company Tufin updates prospectus, says shares approved for NYSE listing. Israel-based Tufin develops network security management software and has previously raised $30 million. Read more

Nasdaq-listed adtech company Perion acquires marketing startup Captain Growth. Captain Growth offers an ad performance analytics service, providing feedback and actionable recommendations to users. Read more

Market indifferent to European approval of Teva's migraine drug. Teva's injection, one of three similar migraine drugs already approved in the U.S., is the third to receive European approval after Amgen Inc. and Novartis AG and Eli Lilly. Read more

IronSource banks on doubled revenues for future acquisitions, report says. The Israel-based web and mobile monetization company expects revenues of $900 million in 2019 and is contemplating an IPO, co-founder Omer Kaplan told Reuters Monday. Read more
share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS